China gives conditional approval for Pfizer COVID pill: drug regulator
US authorizes new antibody drug to fight omicron
11 February 2022Spinal cord implant helps paralysed patients walk again
12 February 2022China gives conditional approval for Pfizer COVID pill: drug regulator
China on Saturday said it had given “conditional” approval for Pfizer’s COVID-19 drug Paxlovid to treat adults with mild to moderate illness and a high risk of developing severe disease.
